1. Generics Bulletin

Hikma Names Injectables Chief Mishlawi As CEO

New Chief Replaces Interim Leader Darwazah Following Olafsson’s Departure Last Year

 
• By Dave Wallace

Hikma’s president of injectables, Riad Mishlawi, has been chosen to become the firm’s new CEO from the start of September. The move comes after a period of success in injectables for Hikma, at the same time as the firm attempts to revive the fortunes of its generics business.

CEO_Desk
Riad Mishlawi has been named as Hikma’s CEO • Source: Shutterstock

After a long wait, Hikma has chosen a new CEO to permanently replace leader Siggi Olafsson who quit the company last year. Longtime Hikma executive Riad Mishlawi, president of the firm’s injectables business, will take over from acting CEO Said Darwazah from 1 September “following a transition period,” with Darwazah returning to his role as executive chairman.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Generics Bulletin